U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
199231199231Stress Hormones and Human Cocaine Use - 7CompletedNo Results AvailableCocaine-Related DisordersDrug: Cocainehttps://ClinicalTrials.gov/show/NCT00000290
199232199232Role of Metabolites in Nicotine Dependence (3) - 6CompletedNo Results AvailableTobacco Use DisorderDrug: Ondansetronhttps://ClinicalTrials.gov/show/NCT00000289
199233199233Role of Metabolites in Nicotine Dependence (2) - 5CompletedNo Results AvailableTobacco Use DisorderDrug: Cotinine fumaratehttps://ClinicalTrials.gov/show/NCT00000288
199234199234Relapse Patterns in Female Cocaine Users - 4CompletedNo Results AvailableCocaine-Related Disordershttps://ClinicalTrials.gov/show/NCT00000287
199235199235Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3CompletedNo Results AvailableCocaine-Related DisordersDrug: Nefazodonehttps://ClinicalTrials.gov/show/NCT00000286
199236199236Effects of Phenytoin on Cocaine Use in Humans - 2CompletedNo Results AvailableCocaine-Related DisordersDrug: Phenytoinhttps://ClinicalTrials.gov/show/NCT00000285
199237199237Role of Metabolites in Nicotine Dependence (1) - 1CompletedNo Results AvailableTobacco Use DisorderDrug: Cotinine fumaratehttps://ClinicalTrials.gov/show/NCT00000284
199238199238Pemoline for Cocaine Abuse - 7CompletedNo Results AvailableCocaine-Related DisordersDrug: Pemolinehttps://ClinicalTrials.gov/show/NCT00000282
199239199239Pharmacotherapy for Schizophrenic Drug Users - 6CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersBehavioral: Amantadinehttps://ClinicalTrials.gov/show/NCT00000281
199240199240Glutaminergic Agents for Cocaine Abuse - 5CompletedNo Results AvailableCocaine-Related DisordersDrug: Nimodipinehttps://ClinicalTrials.gov/show/NCT00000280
199241199241Novel Medications for Opiate Detoxification - 4CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Clonidinehttps://ClinicalTrials.gov/show/NCT00000279
199242199242Disulfiram for Cocaine-Alcohol Abuse - 3CompletedNo Results AvailableAlcohol-Related Disorders|Cocaine-Related DisordersDrug: Disulfiramhttps://ClinicalTrials.gov/show/NCT00000278
199243199243Mazindol for Cocaine Abuse - 2CompletedNo Results AvailableCocaine-Related DisordersDrug: Mazindolhttps://ClinicalTrials.gov/show/NCT00000277
199244199244Dopamine Reuptake Inhibitors of Cocaine Abuse - 1TerminatedNo Results AvailableCocaine-Related DisordersDrug: Bupropionhttps://ClinicalTrials.gov/show/NCT00000276
199245199245Cocaine Abuse and ADHD - 10CompletedNo Results AvailableCocaine-Related DisordersDrug: Flupenthixolhttps://ClinicalTrials.gov/show/NCT00000275
199246199246Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Flupenthixolhttps://ClinicalTrials.gov/show/NCT00000274
199247199247A Laboratory Model for Heroin Abuse Medications - 8CompletedNo Results AvailableHeroin Dependence|Opioid-Related Disorders|Substance-Related DisordersDrug: opiateshttps://ClinicalTrials.gov/show/NCT00000273
199248199248New Approaches to Cocaine Abuse Medications (B) - 7CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00000272
199249199249New Approaches to Cocaine Abuse Medications (A) - 6CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Desipraminehttps://ClinicalTrials.gov/show/NCT00000271
199250199250Brain Imaging: Cocaine Effects & Medication Development - 5CompletedNo Results AvailableCocaine-Related DisordersDrug: Cocainehttps://ClinicalTrials.gov/show/NCT00000270
199251199251Pergolide Treatment for Substance Abusers - 4CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Pergolidehttps://ClinicalTrials.gov/show/NCT00000269
199252199252Cocaine Abuse and Attention Deficit Disorder - 3CompletedNo Results AvailableCocaine-Related DisordersDrug: Bupropionhttps://ClinicalTrials.gov/show/NCT00000268
199253199253Risperidone Treatment in Dually-Diagnosed Individuals - 2CompletedNo Results AvailableCocaine-Related DisordersDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00000267
199254199254Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1CompletedNo Results AvailableCocaine-Related DisordersDrug: Flupenthixolhttps://ClinicalTrials.gov/show/NCT00000266
199255199255Subjective Effects of Nitrous Oxide in Dental Patients - 17CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related Disordershttps://ClinicalTrials.gov/show/NCT00000265
199256199256Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 30% Nitrous oxide|Other: 0.35 g/Kg ethanol|Other: 0.7 g/Kg ethanol|Other: 0 g/Kg ethanolhttps://ClinicalTrials.gov/show/NCT00000264
199257199257Effects of Combined Alcohol and Nitrous Oxide Intake - 15CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 30% Nitrous oxide|Other: 0.25 g/Kg ethanol|Other: 0.5 g/KG ethanol|Other: 0 g/Kg ethanolhttps://ClinicalTrials.gov/show/NCT00000263
199258199258Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 30% Nitrous oxide|Drug: 0.4% Sevoflurane|Drug: 0.2% sevoflurane|Other: Placebohttps://ClinicalTrials.gov/show/NCT00000262
199259199259Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13CompletedNo Results AvailableAlcohol-Related Disorders|Opioid-Related Disorders|Substance-Related DisordersDrug: 30% Nitrous oxide|Other: Placebo|Drug: 0.2% sevoflurane|Drug: 0.4% sevoflurane|Drug: 0.6% sevofluranehttps://ClinicalTrials.gov/show/NCT00000261
199260199260Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Nitrous oxidehttps://ClinicalTrials.gov/show/NCT00000260

* Görseller ve İçerik tekif hakkına sahip olabilir